Your browser doesn't support javascript.
loading
Therapeutic genome engineering: Implications for South Africa
Naidoo, J; Fok, E; Scholefield, J.
Affiliation
  • Naidoo, J; s.af
  • Fok, E; s.af
  • Scholefield, J; s.af
S. Afr. med. j. (Online) ; 109(8): 54-58, 2019. ilus
Article in En | AIM | ID: biblio-1271230
Responsible library: CG1.1
ABSTRACT
South Africa encompasses extraordinary genetic diversity, frequently revealing unique mutations and variations associated with disease. Despite the advances of traditional gene therapy, our understanding of causative mutations in the South African population has, for the most part, contributed to diagnostic rather than therapeutic interventions. Recent developments in genome engineering and its ease of use have released a powerful tool with which to intervene in otherwise untreatable disease. In addition, harnessing this tool for discrete genetic edits provides a mechanism by which screening of new drugs specific to our population's diversity can be accomplished. Here, we use examples of some of the most advanced genome engineering approaches to develop therapeutic strategies that would specifically affect South African individuals
Subject(s)
Search on Google
Database: AIM Main subject: South Africa / Therapeutics / Genetic Engineering / Genome Country/Region as subject: Africa Language: En Journal: S. Afr. med. j. (Online) Year: 2019 Document type: Article
Search on Google
Database: AIM Main subject: South Africa / Therapeutics / Genetic Engineering / Genome Country/Region as subject: Africa Language: En Journal: S. Afr. med. j. (Online) Year: 2019 Document type: Article